Philip Karl Herman - Net Worth and Insider Trading

Philip Karl Herman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Philip Karl Herman owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .

Click here to see the complete history of Philip Karl Herman’s form 4 insider trades.

Insider Ownership Summary of Philip Karl Herman

Ticker	Comapny	Transaction Date	Type of Owner
YMAB	Y-mAbs Therapeutics Inc	2020-01-01	Sr. VP and CCO

Philip Karl Herman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Philip Karl Herman Ownership Network

Ownership Network List of Philip Karl Herman

No Data

Ownership Network Relation of Philip Karl Herman

Philip Karl Herman Owned Company Details

What does Y-mAbs Therapeutics Inc do?

Who are the key executives at Y-mAbs Therapeutics Inc?

Philip Karl Herman is the Sr. VP and CCO of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & EVP & CFO & Secy & Treas. Bo Kruse , director & President and Chairman Thomas Gad , and SVP and CMO Vignesh Rajah .

Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary

Over the past 18 months, Philip Karl Herman made no insider transaction in Y-mAbs Therapeutics Inc (YMAB). Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net purchase of 380,768 shares made by Biotech Aps Wg , a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , and a net sale of 336,251 shares made by Thomas Gad .

In summary, during the past 3 months, insiders sold 92,351 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 92,351 shares. During the past 18 months, 399,644 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 361,892 shares.

Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Y-mAbs Therapeutics Inc Insider Transactions

No Available Data

Philip Karl Herman Mailing Address

Above is the net worth, insider trading, and ownership report for Philip Karl Herman. You might contact Philip Karl Herman via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York Ny 10169.

Discussions on Philip Karl Herman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.